Search

Author/Creator Ochudlo, Stanislaw

1. 134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies. (15th June 2018)

Authors:
Fernandez, Hubert H.; Davis, Mat D.; Factor, Stewart A.; Hauser, Robert A.; Jarskog, L. Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; Ochudlo, Stanislaw; Ondo, William G.; Anderson, Karen E.
Journal:
CNS spectrums
Issue:
Volume 23:Number 1(2018:Feb.)
Page Start:
84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 149 Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study. (15th June 2018)

Authors:
Anderson, Karen E.; Davis, Mat D.; Factor, Stewart A.; Hauser, Robert A.; Jarskog, L. Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; FRCPC, ; Ochudlo, Stanislaw; Ondo, William G.; Fernandez, Hubert H.
Journal:
CNS spectrums
Issue:
Volume 23:Number 1(2018:Feb.)
Page Start:
92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 158 Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study. (15th June 2018)

Authors:
Anderson, Karen E.; Davis, Mat D.; Factor, Stewart A.; Hauser, Robert A.; Jarskog, L. Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; Ochudlo, Stanislaw; Ondo, William G.; Fernandez, Hubert H.
Journal:
CNS spectrums
Issue:
Volume 23:Number 1(2018:Feb.)
Page Start:
97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities. (12th March 2019)

Authors:
Anderson, Karen E.; Stamler, David; Davis, Mat D.; Hauser, Robert A.; Jarskog, L. Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; Ochudlo, Stanislaw; McEvoy, Joseph; Fernandez, Hubert H.
Journal:
CNS spectrums
Issue:
Volume 24:Number 1(2019:Feb)
Page Start:
193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia. (12th March 2019)

Authors:
Anderson, Karen E.; Stamler, David; Davis, Mat D.; Gross, Nicholas; Hauser, Robert A.; Jarskog, L. Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; Ochudlo, Stanislaw; McEvoy, Joseph; Fernandez, Hubert H.
Journal:
CNS spectrums
Issue:
Volume 24:Number 1(2019:Feb)
Page Start:
193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. (August 2017)

Authors:
Anderson, Karen E; Stamler, David; Davis, Mat D; Factor, Stewart A; Hauser, Robert A; Isojärvi, Jouko; Jarskog, L Fredrik; Jimenez-Shahed, Joohi; Kumar, Rajeev; McEvoy, Joseph P; Ochudlo, Stanislaw; Ondo, William G; Fernandez, Hubert H
Journal:
Lancet
Issue:
Volume 4:Number 8(2017)
Page Start:
595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension. (28th November 2017)

Authors:
Gracies, Jean-Michel; Esquenazi, Alberto; Brashear, Allison; Banach, Marta; Kocer, Serdar; Jech, Robert; Khatkova, Svetlana; Benetin, Ján; Vecchio, Michele; McAllister, Peter; Ilkowski, Jan; Ochudlo, Stanislaw; Catus, France; Grandoulier, Anne Sophie; Vilain, Claire; Picaut, Philippe
Journal:
Neurology
Issue:
Volume 89:Number 22(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea: Results of the main phase of a phase 3 study. (December 2018)

Authors:
Jost, Wolfgang H.; Michel, Olaf; Oehlwein, Christian; Slawek, Jaroslaw; Bogucki, Andrzej; Ochudlo, Stanislaw; Banach, Marta; Pagan, Fernando; Flatau-Baqué, Birgit; Csikós, János; Blitzer, Andrew
Journal:
Toxicon
Issue:
Volume 156(2018)Supplement 1
Page Start:
S53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy of incobotulinumtoxinA in subjects with sialorrhea, assessed using the modified radboud oral motor inventory for Parkinson's disease (mROMP). (December 2018)

Authors:
Jost, Wolfgang H.; Michel, Olaf; Oehlwein, Christian; Slawek, Jaroslaw; Bogucki, Andrzej; Ochudlo, Stanislaw; Banach, Marta; Pagan, Fernando; Flatau-Baqué, Birgit; Csikós, János; Blitzer, Andrew
Journal:
Toxicon
Issue:
Volume 156(2018)Supplement 1
Page Start:
S53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea. (December 2018)

Authors:
Pagan, Fernando; Jost, Wolfgang H.; Michel, Olaf; Oehlwein, Christian; Slawek, Jaroslaw; Bogucki, Andrzej; Ochudlo, Stanislaw; Banach, Marta; Flatau-Baqué, Birgit; Csikós, János; Blitzer, Andrew
Journal:
Toxicon
Issue:
Volume 156(2018)Supplement 1
Page Start:
S87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗